Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric D Austin

Showing results (111-120 of 172) with videos related to

Pageof 18
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2025
Circular RNA Profiling Identifies <i>circ5078</i> as a <i>BMPR2</i>-Derived Regulator of Endothelial Proliferation and Stress ResponsesM Martin VandenBroek, Mackenzie C Sharp, Patrick Thompson, et al.
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
The Journal of Pediatrics|June 25, 2017
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary DysplasiaUsha Krishnan, Jeffrey A Feinstein, Ian Adatia, et al.
Children (Basel, Switzerland)|May 27, 2026
Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD CollaborativeShilpa Vyas-Read, Shazia Bhombal, Roopa Siddaiah, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
The Journal of Pediatrics|August 26, 2022
Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network RegistryRachel K Hopper, Steven H Abman, Eleni G Elia, et al.
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
Pageof 18

Showing results (111-120 of 172) with videos related to

Sort By:
Pageof 18
Arteriosclerosis, Thrombosis, and Vascular Biology|August 7, 2025
Circular RNA Profiling Identifies <i>circ5078</i> as a <i>BMPR2</i>-Derived Regulator of Endothelial Proliferation and Stress ResponsesM Martin VandenBroek, Mackenzie C Sharp, Patrick Thompson, et al.
The New England Journal of Medicine|July 26, 2013
A novel channelopathy in pulmonary arterial hypertensionLijiang Ma, Danilo Roman-Campos, Eric D Austin, et al.
Circulation|March 24, 2016
Fatty Acid Metabolic Defects and Right Ventricular Lipotoxicity in Human Pulmonary Arterial HypertensionEvan L Brittain, Megha Talati, Joshua P Fessel, et al.
Chest|February 20, 2021
ST2 Is a Biomarker of Pediatric Pulmonary Arterial Hypertension Severity and Clinical WorseningMegan Griffiths, Jun Yang, Catherine E Simpson, et al.
The Journal of Pediatrics|June 25, 2017
Evaluation and Management of Pulmonary Hypertension in Children with Bronchopulmonary DysplasiaUsha Krishnan, Jeffrey A Feinstein, Ian Adatia, et al.
Children (Basel, Switzerland)|May 27, 2026
Echocardiographic Detection of Pulmonary Hypertension and Right Ventricular Failure in Infants with Bronchopulmonary Dysplasia: A Survey of the BPD CollaborativeShilpa Vyas-Read, Shazia Bhombal, Roopa Siddaiah, et al.
Pediatric Research|September 14, 2020
Pediatric pulmonary hypertension: insulin-like growth factor-binding protein 2 is a novel marker associated with disease severity and survivalMegan Griffiths, Jun Yang, Melanie Nies, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
The Journal of Pediatrics|August 26, 2022
Pulmonary Hypertension in Children with Down Syndrome: Results from the Pediatric Pulmonary Hypertension Network RegistryRachel K Hopper, Steven H Abman, Eleni G Elia, et al.
The Journal of Pediatrics|October 23, 2021
Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary HypertensionMegan Griffiths, Jun Yang, Dhananjay Vaidya, et al.
Pageof 18